definiens: shall mean telev ision, radio, outdoor advertising, direct mail or lay newspa pers, magazines or journals ; ( iii ) in the event that a JV Entity has beg un developing a Ranitidine Product ( if the Relevant Product is a Ranitidine Product ) or ( in any other case ) a product cont aining the same principal active ingredients as the Relevant P roduct ( ) for marketing, sale or distribution in the GW Relevant Country but has not begun mark eting, selling or distributing the Comparable Product in such co untry:<PAGE > ( A ) W - L and GW shall discuss in good faith the viability of developing or continuing to develop a Ranitidine Product or a Comparable Produc t, as the case may be, for marketing, sale or distribution b y a JV Entity in the GW Relevant Country and/or the establ ishment of a co - promotion or co - marketing arrangement with respect to the marketing, sale or distribution of the Re levant Product in the GW Relevant Country, ( B ) if the Parties fail to agree on satisfactory arrangements for such development of a Ra nitidine Product or a Comparable Product or such a co - promoti on or co - marketing arrangement with respect to the Relevant Product, GW shall first have reimbursed, on an after - tax ba sis, all relevant JV Entities and/or W - L and the W - L Partic ipant ( with the principle being that W - L and the W - L Part icipant be made whole ) for all costs ( including reimburse ment costs ) expended or incurred by them or for which they are, or will with the passage of time become, liable i n connection with the development of Ranitidine Products or Comparable Products, as the case may be, specificall y for marketing, sale or distribution in the GW Relevant C ountry, and ( C ) immediately following the reimbu rsement of development costs pursuant to clause ( B ) above, any license granted to any JV Entity in respect of su ch product shall terminate without further action of the P arties ; ( iv ) in the event that a JV Entity shall h ave commenced marketing, selling or distributing Ranitidine Products ( if the Relevant Product is a Ranitidine Product ) or a Comparable Product ( in any other case ) in the GW Relevant Country, and without prejudice to GW 's and its Permitted Af filiates ' rights to market, sell or distribute the Relevant Produc t in the Relevant Country, W - L and GW shall discuss and negotiat e in good faith arrangements with respect to the marketing, sa le and distribution of the Relevant Product and the relevant Ranit idine Product or the Comparable Product, as the case may be, in the GW Relevant Country including the establishment of co - prom otion or co - marketing arrangements with respect to such products ; and ( v ) in the event that a JV Entity shall h ave commenced marketing, selling or distributing Ranitidine Products ( if the Relevant Product is a Ranitidine Product ) or C omparable < PAGE > Products ( in any other case ) in the Relevant C ountry, the Relevant Product shall only be marketed, sold or distributed ( by GW or its Permitted Affiliates ) under trademar ks, trade dress, brand marks, brand names and logos being used by GW or its Affiliates in respect of their prescription bu siness in the Relevant Country as it relates to the Relevant Prescription Product or such other trademarks, trade dress, brand marks, brand names or logos which are different than, and n ot confusingly similar to, those granted to the JV Entity